AstraZeneca cancer drug Lynparza is granted priority review in US Read More
Hutchmed China shares rise on Orphathys and Tagrisso Phase 3 study Read More
LONDON BROKER RATINGS: Hochschild Mining hit with three downgrades Read More
REPEAT: AstraZeneca gets positive results from two trials for Covid-19 Read More
AstraZeneca ges positive results from two AZD7442 trials for Covid-19 Read More
LONDON BROKER RATINGS: Jefferies cuts M&S to Hold from Buy Read More
LONDON MARKET CLOSE: Stocks slide as investors eye UK inflation Read More
LONDON BROKER RATINGS: TT Electronics and Trainline called Buys Read More
AstraZeneca, Moderna post promising findings from heart drug Read More
LONDON MARKET CLOSE: Muted end to US inflation-dominated week Read More
LONDON MARKET MIDDAY: Stocks lack direction amid profit-taking Read More
TOP NEWS SUMMARY: Test case for Japan conglomerates as Toshiba splits Read More
LONDON MARKET OPEN: Astra drags on FTSE 100; pound recovers a bit Read More
TOP NEWS: AstraZeneca profit takes hit but revenue gets Covid booster Read More
LONDON BRIEFING: AstraZeneca holds guidance as vaccine revenue surges Read More
LONDON MARKET PRE-OPEN: Astra revenue up; Wood reviews Consulting unit Read More
LONDON BROKER RATINGS: Four banks positive on Oxford Nanopore Read More
UK earnings, trading statements calendar - next 7 days Read More
LONDON MARKET CLOSE: Stocks fall as markets prepare for Fed meeting Read More
TOP NEWS: Astra transfers drug rights to Covis in USD270 million deal Read More
